What is Truemeds?
Truemeds operates as a technology-driven tele-health platform designed to optimize healthcare outcomes while drastically reducing expenses for patients. By utilizing a proprietary algorithm that facilitates precise scientific matching of medicines, the company enables customers to achieve savings of up to 51% on their pharmaceutical purchases. This value proposition addresses a critical pain point in the Indian healthcare ecosystem, where medicine costs often represent a significant barrier to consistent treatment adherence. Through its integrated model of tele-consultation and digital pharmacy services, Truemeds is not merely a retailer but a strategic intermediary that improves the efficiency of the medicine supply chain, positioning itself as a leader in the digital health transformation of the region.
How much funding has Truemeds raised?
Truemeds has raised a total of $112M across 3 funding rounds:
Series A
$5M
Series B
$22M
Series C
$85M
Series A (2021): $5M with participation from Asha Impact, InfoEdge Ventures, and Indian Angel Network
Series B (2022): $22M led by Westbridge Capital, Asha Impact, and InfoEdge Ventures
Series C (2025): $85M supported by Westbridge Capital Us Advisors, Accel, Info Edge Ventures, and Peak XV Partners
Key Investors in Truemeds
Peak XV Partners
Peak XV Partners is a prominent venture capital firm specializing in early-to-growth stage technology investments across Asia, providing both capital and operational expertise to help founders scale market-defining businesses.
Westbridge Capital Us Advisors
WestBridge Capital is an investment firm focused on long-term growth and sustainable solutions, partnering with Indian entrepreneurs to strengthen the nation's position in the global technology and healthtech sectors.
Accel
Accel is a global venture capital firm that partners with exceptional teams from the inception of their ideas through all phases of private company growth, offering strategic guidance to scale effectively.
What's next for Truemeds?
With the successful closure of its latest financing round, Truemeds is well-positioned to accelerate its market penetration and enhance its technological infrastructure. The strategic focus will likely shift toward expanding its tele-consultation capabilities and refining its matching algorithms to cover a broader spectrum of therapeutic areas. As the company moves into this next phase of growth, it will prioritize scaling its logistics network and deepening its integration with healthcare providers to ensure seamless service delivery. The backing from prominent institutional investors provides the necessary runway to navigate the competitive landscape of Indian healthtech, allowing Truemeds to focus on long-term sustainability and the continued democratization of essential medical services.
See full Truemeds company page
